MIMETAS, a global provider in human disease modeling, has expanded its ongoing partnership with Astellas to include automation and application support.   The Mimetas and Astellas partnership began in 2016 by accepting three scientists from Astellas for hands-on training at MIMETAS. In March 2023, the companies entered a strategic partnership to devise novel immuno-oncology therapies based on MIMETAS’ comprehensive tumor models. This partnership expands Astellas’ adoption of the MIMETAS platfor...